The p16 and p18 tumor suppressor genes in neuroblastoma: Implications for drug resistance

Cancer Letters

Volumn 104, Issue 2, 1996, Pages 183-192

  Diccianni, Mitchell B ^a   Chau, Lan S ^a   Batova, Ayse ^a   Vu, Thai Q ^a   Yu, Alice L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclin dependent kinase inhibitor; Hypermethylation; Neuroblastoma; p16; p18

Indexed keywords

BETA INTERFERON; CYCLIN DEPENDENT KINASE; DOXORUBICIN; PROTEIN KINASE INHIBITOR;

ARTICLE; CHROMOSOME 9P; CONTROLLED STUDY; DRUG RESISTANCE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029943442     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04250-4     Document Type: Article

References (23)

1. Sherr, C.J. (1993) Mammalian G1 cyclins. Cell, 73, 1059-1065.
2. Hartwell, L. (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71, 543-546.
3. Nurse, P. (1990) Universal control mechanism regulating onset of M-phase. Nature (London), 344, 503-508.
4. Tam, S.W., Shay, J.W. and Pagano, M. (1994) Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res., 54, 5816-5829.
5. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K. and Carson, D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (London), 368, 753-756.
6. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stocker, T.E., Day, R.S. III., Johnson, B.E. and Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington, DC), 264, 436-440.
7. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
8. Diaz., M.O., Rubin, C.M., Harden, A. Ziemin, S., Larson, R.A., Le Beau, M.M. and Rowley, J.D. (1990) Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med., 322, 77-82.
9. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321-2330.
10. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin. S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692.
11. Gonzalez-Zulueta, M., Bender, C.M., Yang, Y.S., Nguyen, T., Beart, R.W., Van Tornout, J.M. and Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-41535.
12. Brodeur, G.M., Sekhon, G.S. and Goldstein, M.N. (1977) Chromosomal aberrations in human neuroblastoma. Cancer, 40, 2256-2263.
13. Schleiermacher, G., Peter, M., Michon, J., Hugot, J.-P., Vielh, P., Zucker, J.-M., Magdelenat, H., Thomas, G. and Delattre, O. (1995) Two distinct deleted regions on the short arm of chromosome I in neuroblastomas. Genes Chrom. Cancer, 10, 275-281.
14. Brodeur, G.M. and Fong, C-T. (1989) Molecular biology and genetics of human neuroblastoma. Cancer Gen. Cytogen., 41, 153-174.
15. Lois, A.F., Cooper, L.T., Geng, Y., Nobori, T. and Carson, D. (1995) Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res., 55, 4010-4013.
16. Beck, W.T., Mueller, T.J. and Tanzer, L.R. (1979) Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res., 39, 2070-2076.
17. Reynolds, C.P., Bliedler, J.L., Spengler, B.A., Reynolds, D.A., Ross, R.A., Frenkel, E.P. and Smith, R.G. (1988) Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst., 76, 375-387.
18. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J-P., J., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the p16/CDKN2/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
19. INK4B/MTS2 on human leukemias and lymphomas. Cancer Res., 55, 1436-1440.
20. Lahti, J.M., Valentine, M., Xiang, J., Jones, B., Joseph, A., Grenet, J., Richmond, G., Look, A.T. and Kidd, V.J. (1994) Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet., 7, 370-375.
21. Diccianni, MB., Yu, J., Hsiao, M., Mukerjee, S., Shao, L.E. and Yu A.L. (1994) Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood, 84, 3105-3112.
22. Okamoto, A., Hussain, S.P., Hagiwara, K., Spillare, E.A., Rusin, M.R., Demetrick, D.J., Serrano, M., Hannon, G.J., Shiseki, M., Zariwala, M., Xiong, Y., Beach, D.H., Yokota, J. and Harris, C.C. (1995) Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451.
23. Beltinger, C.P., White, P.S., Sulman, E.P., Maris, J.M. and Brodeur, G.M. (1995) No CDKN2 mutations in neuroblastomas. Cancer Res., 55, 2053-2055.